Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Three core operating platforms that tenant companies can access without the burden of building their own facilities. Each represents infrastructure that would be prohibitively expensive for a single startup, yet, through Zeme’s shared model, every tenant benefits.

A tenant company avoids 30–50% of its early CapEx by sharing the line rather than building its own.

Diagnostic and biologic startups ship their first product in a fraction of the time it would take to commission a private facility.

When a tenant outgrows the shared line, build-to-suit GMP suites at LePIP are the planned graduation step and not a vendor change.

Bioreactor capacity for microbial and mammalian production. Available pay-per-run or as a graduation suite. Sized for diagnostic kit and biologic API runs.

Formulation, fill–finish, and packaging for therapeutics graduating out of the venture studio into LePIP build-to-suit suites.

Ecochest is the proof point — five LAMP diagnostic kits and seven STEM kits are already shipping out of this line. Open to tenant assembly with shared QA/QC.
Copyright © 2026 Zeme - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.